1. NIEHS/FDA CLARITY-BPA research program update.
- Author
-
Heindel JJ, Newbold RR, Bucher JR, Camacho L, Delclos KB, Lewis SM, Vanlandingham M, Churchwell MI, Twaddle NC, McLellen M, Chidambaram M, Bryant M, Woodling K, Gamboa da Costa G, Ferguson SA, Flaws J, Howard PC, Walker NJ, Zoeller RT, Fostel J, Favaro C, and Schug TT
- Subjects
- Animals, Biomedical Research organization & administration, Cooperative Behavior, Dose-Response Relationship, Drug, Environmental Exposure adverse effects, Female, Humans, Interinstitutional Relations, Male, Models, Animal, Program Development, Program Evaluation, Risk Assessment, Toxicology organization & administration, Benzhydryl Compounds adverse effects, Biomedical Research methods, Environmental Pollutants adverse effects, Phenols adverse effects, Toxicology methods
- Abstract
Bisphenol A (BPA) is a chemical used in the production of numerous consumer products resulting in potential daily human exposure to this chemical. The FDA previously evaluated the body of BPA toxicology data and determined that BPA is safe at current exposure levels. Although consistent with the assessment of some other regulatory agencies around the world, this determination of BPA safety continues to be debated in scientific and popular publications, resulting in conflicting messages to the public. Thus, the National Toxicology Program (NTP), National Institute of Environmental Health Sciences (NIEHS), and U.S. Food and Drug Administration (FDA) developed a consortium-based research program to link more effectively a variety of hypothesis-based research investigations and guideline-compliant safety testing with BPA. This collaboration is known as the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA). This paper provides a detailed description of the conduct of the study and a midterm update on progress of the CLARITY-BPA research program., (Published by Elsevier Inc.)
- Published
- 2015
- Full Text
- View/download PDF